Gyre Therapeutics Share Price (NASDAQ: GYRE)
$7.72
Last updated on
Check the interactive Gyre Therapeutics Stock chart to analyse performance
Gyre Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$7.72Today's High:$8.32
0.0%
Downside
Day's Volatility :7.21%
Upside
7.21%
- 52 Weeks Low:$6.1152 Weeks High:$19.00
20.85%
Downside
52 Weeks Volatility :67.84%
Upside
59.37%
Gyre Therapeutics Stock Returns
Gyre Therapeutics Inc Key Stats
Check Gyre Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Gyre Therapeutics Stock including INR - Dollar returns
The Gyre Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Gyre Therapeutics investment value today
Current value as on today
₹61,348
Returns
Returns from Gyre Therapeutics Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Gyre Therapeutics Stock
Analyst Recommendation on Gyre Therapeutics Stock
Sell
0%Buy
50%Hold
50%Sell
Based on 6 Wall street analysts offering stock ratings for Gyre Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Gyre Therapeutics Share Price Target
What analysts predicted
Upside of 146.11%
Target:
$19.00
Current:
$7.72
Gyre Therapeutics share price target is $19.00, a slight Upside of 146.11% compared to current price of $7.72 as per analysts' prediction.
Gyre Therapeutics Stock Insights
Price Movement
In the last 7 days, GYRE stock has moved down by -5.5%Increasing Revenue
Revenue is up for the last 2 quarters, 22.05M → 26.77M (in $), with an average increase of 17.6% per quarterDecreasing Net Profit
Netprofit is down for the last 2 quarters, 2.69M → 442.0K (in $), with an average decrease of 83.6% per quarterGYRE vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 113.8%Price to Sales
ForGYRE every $1 of sales, investors are willing to pay $6.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Gyre Therapeutics Inc Financials
Gyre Therapeutics Technicals Summary
Sell
Neutral
Buy
Gyre Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Gyre Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 9.65% | -32.37% | -36.74% | 14.86% | 14.86% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 414.0 | 414.0 | NA | 0.17 | 0.08 | 0.04 | NA | 1.01 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Sell | $752.0M | 14.86% | 414.0 | 4.08% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Gyre Therapeutics Inc
Key Management of Gyre Therapeutics Inc
Important FAQs about investing in GYRE Stock from India :
What is Gyre Therapeutics share price today?
Gyre Therapeutics share price today is $7.72 as on at the close of the market. Gyre Therapeutics share today touched a day high of $8.32 and a low of $7.72.
What is the 52 week high and 52 week low for Gyre Therapeutics share?
Gyre Therapeutics share touched a 52 week high of $19.00 and a 52 week low of $6.11. Gyre Therapeutics stock price today i.e. is closed at $7.72, lower by 59.37% versus the 52 week high.
How to invest in Gyre Therapeutics Stock (GYRE) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Gyre Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Gyre Therapeutics Shares that will get you 0.1943 shares as per Gyre Therapeutics share price of $7.72 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Gyre Therapeutics Stock (GYRE) from India?
Indian investors can start investing in Gyre Therapeutics (GYRE) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Gyre Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Gyre Therapeutics share’s latest price of $7.72 as on August 30, 2025 at 1:29 am IST, you will get 1.2953 shares of Gyre Therapeutics. Learn more about
fractional shares .
What are the returns that Gyre Therapeutics has given to Indian investors in the last 5 years?
Gyre Therapeutics stock has given 14.86% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
- Cambria Value And Momentum Etf
$32.55
+0.25%